Page last updated: 2024-09-04

2'-fluorothymidine and zalcitabine

2'-fluorothymidine has been researched along with zalcitabine in 3 studies

Compound Research Comparison

Studies (2'-fluorothymidine)	Trials (2'-fluorothymidine)	Recent Studies (post-2010) (2'-fluorothymidine)	Studies (zalcitabine)	Trials (zalcitabine)	Recent Studies (post-2010) (zalcitabine)
187	18	39	1,250	155	106

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, YC; Fu, L; Liu, SH	1
Cheng, YC	1
Avci, A; Erhardt, A; Häussinger, D; Heintges, T; Lörke, J; Sagir, A	1

Reviews

1 review(s) available for 2'-fluorothymidine and zalcitabine

Article	Year
[New approaches in the treatment of hepatitis B]. Deutsche medizinische Wochenschrift (1946), 2004, May-21, Volume: 129, Issue:21 Topics: 2-Aminopurine; Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Contraindications; Deoxycytidine; Emtricitabine; Famciclovir; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Organophosphorus Compounds; Polyethylene Glycols; Prodrugs; Prognosis; Recombinant Proteins; Tenofovir; Zalcitabine	2004

Article

Year

[New approaches in the treatment of hepatitis B].

Deutsche medizinische Wochenschrift (1946), 2004, May-21, Volume: 129, Issue:21

Topics: 2-Aminopurine; Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Contraindications; Deoxycytidine; Emtricitabine; Famciclovir; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Organophosphorus Compounds; Polyethylene Glycols; Prodrugs; Prognosis; Recombinant Proteins; Tenofovir; Zalcitabine

2004

Other Studies

2 other study(ies) available for 2'-fluorothymidine and zalcitabine

Article	Year
Sensitivity of L-(-)2,3-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues. Biochemical pharmacology, 1999, Jun-15, Volume: 57, Issue:12 Topics: Acyclovir; Adenine; Antiviral Agents; Arabinofuranosyluracil; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Drug Resistance, Multiple; Guanine; Hepatitis B virus; Lamivudine; Microbial Sensitivity Tests; Mutation; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Zalcitabine	1999
Potential use of antiviral L(-)nucleoside analogues for the prevention or treatment of viral associated cancers. Cancer letters, 2001, Volume: 162 Suppl Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Dioxolanes; Hepatitis B virus; Herpesvirus 4, Human; Humans; Neoplasms; Nucleosides; Stereoisomerism; Structure-Activity Relationship; Uracil; Virus Diseases; Zalcitabine	2001

Article

Year

Sensitivity of L-(-)2,3-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues.

Biochemical pharmacology, 1999, Jun-15, Volume: 57, Issue:12

Topics: Acyclovir; Adenine; Antiviral Agents; Arabinofuranosyluracil; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Drug Resistance, Multiple; Guanine; Hepatitis B virus; Lamivudine; Microbial Sensitivity Tests; Mutation; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Zalcitabine

1999

Potential use of antiviral L(-)nucleoside analogues for the prevention or treatment of viral associated cancers.

Cancer letters, 2001, Volume: 162 Suppl

Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Dioxolanes; Hepatitis B virus; Herpesvirus 4, Human; Humans; Neoplasms; Nucleosides; Stereoisomerism; Structure-Activity Relationship; Uracil; Virus Diseases; Zalcitabine

2001